STOCK TITAN

Forte Biosciences, Inc. (FBRX) Net Income by Year

FBRX

Forte Biosciences, Inc. reported a net loss of $69.4M in fiscal year 2025. This represents a decrease of 95.5% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Forte Biosciences, Inc. has filed alongside them.

FY2025 annual
Net Income -$69.4M
YoY -95.5%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

FBRX Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25DEF 14AFY24DEF 14AFY23DEF 14AFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-K
Net Income-$69.4M-95.5%-$35.5M-12.7%-$31.5M-126.8%-$13.9M+36.1%-$21.7M+53.3%-$46.5M-1042.5%-$4.1M+91.7%-$49.0M-25.8%-$38.9M-16.3%-$33.5M-45.2%-$23.1M

FBRX Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$23.3M-107.4%-$22.1M-41.4%N/A-$17.7M-110.7%-$11.2M+10.1%-$15.7M-111.0%N/A-$8.4M+15.7%-$12.5M-40.6%-$7.4M-9.9%N/A-$10.0M-192.8%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Forte Biosciences, Inc. financials

Frequently Asked Questions

What was Forte Biosciences, Inc.'s net income in fiscal year 2025?

Forte Biosciences, Inc. reported a net loss of $69.4M in fiscal year 2025.

How fast is Forte Biosciences, Inc.'s net income growing?

Forte Biosciences, Inc. (FBRX) net income fell by 95.5% year over year, from -$35.5M to -$69.4M in fiscal year 2025.

How has Forte Biosciences, Inc.'s net income changed over the years?

Across the 11 fiscal years this page covers, Forte Biosciences, Inc. (FBRX) net income went from -$23.1M in fiscal year 2015 to -$69.4M in fiscal year 2025.

Forte Biosciences, Inc. (FBRX) reported -$23.3M in net income in Q2 2026. This represents a decrease of 107.4% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Forte Biosciences, Inc. (FBRX) reported on that line in every period on record.